Tempus AI, Inc. (NASDAQ:TEM) Receives $69.50 Average Price Target from Analysts

Shares of Tempus AI, Inc. (NASDAQ:TEM) have received a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are covering the company, MarketBeat reports. Six investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 1 year price target among brokers that have covered the stock in the last year is $70.1667.

TEM has been the topic of several recent research reports. Bank of America lifted their price target on Tempus AI from $68.00 to $70.00 and gave the company a “neutral” rating in a research note on Wednesday, June 25th. Guggenheim lifted their target price on Tempus AI from $65.00 to $75.00 and gave the company a “buy” rating in a research report on Monday, June 30th. Piper Sandler reaffirmed a “neutral” rating on shares of Tempus AI in a research report on Friday, August 8th. HC Wainwright lifted their target price on Tempus AI from $90.00 to $98.00 and gave the company a “buy” rating in a research report on Friday. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $70.00 target price on shares of Tempus AI in a research report on Friday, August 8th.

Insider Buying and Selling at Tempus AI

In related news, EVP Erik Phelps sold 51,317 shares of Tempus AI stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $72.56, for a total transaction of $3,723,561.52. Following the completion of the transaction, the executive vice president owned 97,779 shares in the company, valued at approximately $7,094,844.24. This trade represents a 34.42% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Eric P. Lefkofsky sold 332,500 shares of Tempus AI stock in a transaction dated Wednesday, August 27th. The stock was sold at an average price of $74.10, for a total value of $24,638,250.00. Following the transaction, the chief executive officer owned 9,207,533 shares of the company’s stock, valued at $682,278,195.30. The trade was a 3.49% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 903,104 shares of company stock valued at $63,733,330 in the last three months. Corporate insiders own 26.27% of the company’s stock.

Hedge Funds Weigh In On Tempus AI

Hedge funds and other institutional investors have recently bought and sold shares of the business. Concord Wealth Partners grew its holdings in Tempus AI by 308.0% during the second quarter. Concord Wealth Partners now owns 408 shares of the company’s stock worth $26,000 after purchasing an additional 308 shares during the period. Allworth Financial LP boosted its holdings in shares of Tempus AI by 5,000.0% during the second quarter. Allworth Financial LP now owns 459 shares of the company’s stock worth $29,000 after acquiring an additional 450 shares during the period. SouthState Corp boosted its holdings in shares of Tempus AI by 3,761.5% during the second quarter. SouthState Corp now owns 502 shares of the company’s stock worth $32,000 after acquiring an additional 489 shares during the period. Cherry Tree Wealth Management LLC bought a new stake in shares of Tempus AI during the first quarter worth approximately $31,000. Finally, University of Texas Texas AM Investment Management Co. bought a new stake in shares of Tempus AI during the first quarter worth approximately $33,000. Institutional investors own 24.22% of the company’s stock.

Tempus AI Stock Performance

Shares of Tempus AI stock opened at $86.38 on Friday. The company has a market capitalization of $15.01 billion, a PE ratio of -72.59 and a beta of 5.08. Tempus AI has a 12 month low of $31.36 and a 12 month high of $91.45. The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58. The stock’s fifty day simple moving average is $67.61 and its 200 day simple moving average is $59.59.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings results on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.23) by $0.01. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The firm had revenue of $314.64 million for the quarter, compared to the consensus estimate of $296.84 million. During the same quarter last year, the business posted ($6.86) EPS. The company’s revenue for the quarter was up 89.5% on a year-over-year basis. Tempus AI has set its FY 2025 guidance at EPS. On average, research analysts predict that Tempus AI will post -6.15 EPS for the current year.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.